Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity

Medicine & Life Sciences

• Arginase 100%
• Myeloid Cells 78%
• Immunity 62%
• Adenocarcinoma of Lung 27%
• Neoplasms 24%
• Arginine 23%
• T-Lymphocytes 15%
• RNA Sequence Analysis 14%
• Lung 13%
• Therapeutics 12%
• Myeloid-Derived Suppressor Cells 8%
• Essential Amino Acids 8%
• Nitric Oxide Synthase 6%
• Non-Small Cell Lung Carcinoma 5%
• In Vitro Techniques 5%
• Lung Neoplasms 5%
• Cell Count 4%
• Maintenance 4%
• Immunohistochemistry 4%
• Lymphocytes 4%
• Enzymes 3%
• Growth 3%
• Population 2%